Rubicon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has sixty-three approved drugs.
There is one tentative approval on RUBICON drugs.
Drugs and US Patents for Rubicon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rubicon | OXCARBAZEPINE | oxcarbazepine | TABLET;ORAL | 207717-003 | Mar 5, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | BACLOFEN | baclofen | INJECTABLE;INTRATHECAL | 217324-002 | Feb 22, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 075521-005 | Mar 16, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | SILDENAFIL CITRATE | sildenafil citrate | TABLET;ORAL | 204883-001 | Jun 20, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Rubicon | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 214415-002 | Oct 27, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.